<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2015.3894</article-id>
<article-id pub-id-type="publisher-id">mmr-12-03-4546</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>NADPH oxidase-derived production of reactive oxygen species is involved in learning and memory impairments in 16-month-old female rats</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>KAN</surname><given-names>HONGWEI</given-names></name><xref rid="af1-mmr-12-03-4546" ref-type="aff">1</xref><xref rid="af2-mmr-12-03-4546" ref-type="aff">2</xref><xref rid="fn1-mmr-12-03-4546" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>HU</surname><given-names>WEN</given-names></name><xref rid="af1-mmr-12-03-4546" ref-type="aff">1</xref><xref rid="fn1-mmr-12-03-4546" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>YUCHAN</given-names></name><xref rid="af1-mmr-12-03-4546" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>WU</surname><given-names>WANGYANG</given-names></name><xref rid="af1-mmr-12-03-4546" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>YIN</surname><given-names>YANYAN</given-names></name><xref rid="af1-mmr-12-03-4546" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>LIANG</surname><given-names>YAN</given-names></name><xref rid="af2-mmr-12-03-4546" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>CHUNYAN</given-names></name><xref rid="af2-mmr-12-03-4546" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>HUANG</surname><given-names>DAKE</given-names></name><xref rid="af3-mmr-12-03-4546" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>LI</surname><given-names>WEIZU</given-names></name><xref rid="af1-mmr-12-03-4546" ref-type="aff">1</xref><xref ref-type="corresp" rid="c1-mmr-12-03-4546"/></contrib></contrib-group>
<aff id="af1-mmr-12-03-4546">
<label>1</label>Department of Pharmacology, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, Anhui 230032, P.R. China</aff>
<aff id="af2-mmr-12-03-4546">
<label>2</label>Laboratory of Pharmacology, Anhui Institute of Materia Medica, Hefei, Anhui 230022, P.R. China</aff>
<aff id="af3-mmr-12-03-4546">
<label>3</label>Synthetic Laboratory of Basic Medicine College, Anhui Medical University, Hefei, Anhui 230032, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-12-03-4546">Correspondence to: Dr Weizu Li, Department of Pharmacology, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, 81 Meishanlu, Hefei, Anhui 230032, P.R. China, E-mail: <email>liweizu@126.com</email></corresp><fn id="fn1-mmr-12-03-4546">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2015</year></pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>06</month>
<year>2015</year></pub-date>
<volume>12</volume>
<issue>3</issue>
<fpage>4546</fpage>
<lpage>4553</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>05</month>
<year>2014</year></date>
<date date-type="accepted">
<day>04</day>
<month>04</month>
<year>2015</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2015, Spandidos Publications</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Women undergoing the natural menopause can experience progressive cognitive dysfunction, particularly in the form of memory impairment. However, the mechanisms underlying memory impairments in the menopause remain to be elucidated. There is increasing evidence that oxidative damage caused by excessive reactive oxygen species (ROS) production may correlate with age-associated cognitive impairment. The nicotinamide adenosine dinucleotide phosphate oxidase (NOX) family is important in the generation of ROS in the brain. It has been hypothesized that the accumulation of ROS, derived from NOX, may be involved in menopause-associated learning and memory impairments. The present study investigated whether NOX-derived ROS generation affected the learning and memory ability in 3-month and 16-month-old female rats. The results of a morris water maze assessment revealed that there were significant learning and memory impairments in the 16-month-old female rats. Furthermore, the activity of superoxide dismutase (SOD), level of malondialdehyde (MDA), production of ROS and expression levels of NOX2, p47<italic>phox</italic>, Ras-related C3 botulinum toxin substrate 1 (RAC1) and protein kinase C &#x003B1; (PKC&#x003B1;) were investigated in the cortex and hippocampus of 3-month and 16-month old female rats. The results demonstrated that the activity of SOD was significantly decreased, whereas the levels of MDA, production of ROS and expression levels of NOX2, p47<italic>phox</italic>, RAC1 and PKC&#x003B1; were significantly increased in the 16-month old female rats. These results suggested that NOX-mediated oxidative stress may be important in menopause-associated learning and memory impairments.</p></abstract>
<kwd-group>
<kwd>menopause</kwd>
<kwd>learning and memory impairments</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>NADPH oxidase</kwd>
<kwd>Morris water maze</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Natural menopause is a gradual process, which occurs for the majority of women between the ages of 47 and 55 years (<xref rid="b1-mmr-12-03-4546" ref-type="bibr">1</xref>). During the menopause transition, the majority of women report memory problems (<xref rid="b2-mmr-12-03-4546" ref-type="bibr">2</xref>). Numerous studies have revealed that females undergoing surgical or natural menopause may experience memory impairment (<xref rid="b3-mmr-12-03-4546" ref-type="bibr">3</xref>,<xref rid="b4-mmr-12-03-4546" ref-type="bibr">4</xref>), which has been reproduced in adult ovariectomized female rats and mice (<xref rid="b5-mmr-12-03-4546" ref-type="bibr">5</xref>,<xref rid="b6-mmr-12-03-4546" ref-type="bibr">6</xref>). Previous studies have indicated that unilateral and bilateral oophorectomy preceding the onset of the menopause is associated with an increased risk of cognitive impairment or dementia (<xref rid="b3-mmr-12-03-4546" ref-type="bibr">3</xref>,<xref rid="b4-mmr-12-03-4546" ref-type="bibr">4</xref>). This risk was observed to increase with younger age at oophorectomy (<xref rid="b7-mmr-12-03-4546" ref-type="bibr">7</xref>). However, the mechanisms underlying memory impairment in the menopause remain to be elucidated. A previous study demonstrated that a low level of endogenous estrogen in the serum was associated with increased risk of poor verbal memory (<xref rid="b8-mmr-12-03-4546" ref-type="bibr">8</xref>), while other studies have failed to confirm this (<xref rid="b9-mmr-12-03-4546" ref-type="bibr">9</xref>,<xref rid="b10-mmr-12-03-4546" ref-type="bibr">10</xref>). These reports suggest that there are other mechanisms, which are involved in cognitive impairments in menopause.</p>
<p>There is increasing evidence that oxidative damage caused by excess reactive oxygen species (ROS) may correlate with several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease (<xref rid="b11-mmr-12-03-4546" ref-type="bibr">11</xref>&#x02013;<xref rid="b13-mmr-12-03-4546" ref-type="bibr">13</xref>). Excessive ROS can cause oxidative damage via the modification of proteins, lipids and DNA, and the brain is particularly vulnerable to the oxidative damage caused by ROS as it consumes large quantities of oxygen and has an abundant lipid content, but a relative paucity of antioxidant compounds, compared with other organs (<xref rid="b14-mmr-12-03-4546" ref-type="bibr">14</xref>,<xref rid="b15-mmr-12-03-4546" ref-type="bibr">15</xref>).</p>
<p>There are multiple potential sources for ROS in mammalian cells, including the mitochondrial electron transport chain, xanthine oxidase, cyclooxygenases and monoamine oxidases (<xref rid="b16-mmr-12-03-4546" ref-type="bibr">16</xref>,<xref rid="b17-mmr-12-03-4546" ref-type="bibr">17</xref>). However, the nicotinamide adenosine dinucleotide phosphate oxidase enzyme (NADPH oxidase; NOX) is important, as it is dedicated to the specific production of superoxide. Superoxide production via NADPH oxidase has been demonstrated to be important in a variety of neurological disorders, including Alzheimer's disease. NOX is composed of membrane-bound (gp91<italic>phox</italic>, also termed NOX2 and p22<italic>phox</italic>) and cytoplasmic subunits &#x0005B;p40<italic>phox</italic>, p47<italic>phox</italic>, p67<italic>phox</italic> and Ras-related C3 botulinum toxin substrate 1 (RAC1)&#x0005D; (<xref rid="b18-mmr-12-03-4546" ref-type="bibr">18</xref>). NOX2 is expressed throughout the central nervous system and its levels are particularly high in neurons, astrocytes and microglia (<xref rid="b19-mmr-12-03-4546" ref-type="bibr">19</xref>). NOX2 has been implicated in nerve growth factor signaling and may be important in the plasticity of the nervous system, including learning and memory formation (<xref rid="b20-mmr-12-03-4546" ref-type="bibr">20</xref>). Previous studies have demonstrated that the p67<italic>phox</italic>, p47<italic>phox</italic> and p40<italic>phox</italic> NOX cytosolic subunit proteins are significantly elevated with the progression of Alzheimer's disease (<xref rid="b18-mmr-12-03-4546" ref-type="bibr">18</xref>,<xref rid="b20-mmr-12-03-4546" ref-type="bibr">20</xref>). In addition, a marked correlation has been observed between NOX activity and cognitive status, in which as NOX activity increased, cognitive performance decreased (<xref rid="b18-mmr-12-03-4546" ref-type="bibr">18</xref>). The present study hypothesized that oxidative damage caused by NADPH oxidase-derived ROS accumulation may be involved in the learning and memory impairments in menopause, and learning and memory abilities, the activity of superoxide dismutase (SOD), the level of malondialdehyde (MDA) and NADPH oxidase-derived ROS accumulation were investigated in 3-and 16-month-old female rats to confirm this hypothesis.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Animals and treatment</title>
<p>The animal experiments were approved by the Institutional Animal Care and Use Committee of Anhui Medical University (Hefei, China). Sprague Dawley rats were obtained from the Shanghai B&amp;K Universal Group Limited (Shanghai, China). Female adolescent rats (3 months; 210&#x02013;260 g) and female aged rats (16-months; 490&#x02013;540 g) rats were used in the present study (17 animals in each group). All animals were housed in standard cages with a 12 h light/dark cycle and had <italic>ad libitum</italic> access to food and water throughout the investigation. The animals were allowed to acclimate to their new surroundings for 1 week prior to the commencement of the behavioral experiments.</p></sec>
<sec>
<title>Morris water maze</title>
<p>The water maze consisted of a plastic black circular tank (160 cm in diameter; 60 cm high). An overhead video camera connected to a computer and ANY-maze video tracking system software (Stoelting Company, Wood Dale, IL, USA) was used to track the path of movement of the rat. The water was maintained at a constant temperature of 22&#x02013;25&#x000B0;C. A circular escape platform (10 cm diameter) was placed 2 cm below the surface of the water, in the middle of one of the four quadrants. The general assessment process has been described in detail previously (<xref rid="b21-mmr-12-03-4546" ref-type="bibr">21</xref>,<xref rid="b22-mmr-12-03-4546" ref-type="bibr">22</xref>). In the training trials, the animals were placed into the tank from the four quadrants each day, with a 5 min trial interval, for 4 days. Each trial lasted until the rats climbed onto the hidden platform within 90 sec, the rats were guided to the platform if they had not climbed onto the platform within 90 sec. The escape latency onto the platform was recorded to indicate the learning performance. Following the training trials, the platform was removed from the pool and each rat received one swim probe trial of 60 sec. The swimming distance (m) and the mean speed (m/sec) were recorded as an indication of motor behavior. The swimming duration in the quadrant of the platform (sec), swimming distance in the quadrant of the platform (m), number of crossings of the platform and time of first entry onto the platform (sec) were recorded as an indicator of memory aptitude.</p></sec>
<sec>
<title>Levels of serum estradiol and luteinizing hormone (LH)</title>
<p>The levels of serum estradiol and LH were measured using an automated microparticle enzyme immunoassay kit and analysis instrument (AxSYM; Abbott Diagnostics, Inc., Abbott Park, IL, USA). The AxSYM method is a heterogeneous immunoassay, in which estradiol and LH from the specimens bind to rabbit polyclonal anti-estradiol antibodies and anti-LH antibodies, which are linked to microparticles. Following removal of the unbound materials, estradiol and LH alkaline phosphatase conjugate were added and bound to available sites. Following washing with PBS, 4-methylum-belliferyl phosphate was added and the fluorescent product was measured. In this method, the intensity of the signal is inversely proportional to the concentrations of estradiol and LH in the specimens (<xref rid="b23-mmr-12-03-4546" ref-type="bibr">23</xref>,<xref rid="b24-mmr-12-03-4546" ref-type="bibr">24</xref>).</p></sec>
<sec>
<title>Activity of SOD and content of MDA in brain tissue</title>
<p>The animals were sacrificed via cervical dislocation (eight rats in each group). The brain was immediately dissected in half along the coronal line, one half of which was frozen (&#x02212;8&#x000B0;C) for immunoblot analysis and the other was used to form a 10% physiological saline homogenate. The homogenate was centrifuged at 4,000 x g for 10 min, and the supernatant was collected. The activity of SOD and the level of MDA were detected using a spectrophotometer (SpectraMax 190; Molecular Devices Corp., Sunnyvale, CA, USA), according to the SOD and MDA assay kits (Niajing Jiancheng Bioengineering Institute, Nanjing, China).</p></sec>
<sec>
<title>Production of ROS in the frontal cortex and hippocampus</title>
<p>Dihydroethidium (DHE) microfluorography (Beyotime Institute of Biotechnology, Haimen, China) was used to determine the production of ROS in the brain tissue (<xref rid="b25-mmr-12-03-4546" ref-type="bibr">25</xref>). DHE is a cell permeable dye, which is oxidized to ethidium bromide and associated products by superoxide. Ethidium bromide is trapped intracellularly by intercalation into DNA and can then be identified using red fluorescence (<xref rid="b26-mmr-12-03-4546" ref-type="bibr">26</xref>,<xref rid="b27-mmr-12-03-4546" ref-type="bibr">27</xref>). In the present study, DHE was injected via the vena caudalis (100 <italic>&#x000B5;</italic>M; 1 ml/100 g) for 30 min prior to sacrifice of the rat (n=8; four rats/group). The brains were removed from the skull and transferred to a freezer at &#x02212;20&#x000B0;C. Subsequently, the brains were sectioned at a thickness of 20 <italic>&#x000B5;</italic>m using a cryostat section cutter (Leica, Wetzlar, Germany) at &#x02212;20&#x000B0;C and mounted onto glass slides. The sections were washed with phosphate buffered saline three times and examined using a fluorescence microscope (Olympus IX71; Olympus, Tokyo, Japan) equipped with a custom filter set for detection of DHE oxidation products (red). The production of ROS in the cortex and the hippocampal CA1 and CA3 regions were assessed using previously described methods (<xref rid="b25-mmr-12-03-4546" ref-type="bibr">25</xref>). The exposure time was 900 ms for all sections. A total of four sections per group were assessed for ROS quantitative analysis. The mean fluorescence intensities of three consecutive fields (magnification, &#x000D7;400) in the cortex, and hippocampal CA1 and CA3 regions, were performed in a blinded-manner using the Image-Pro Plus 6.0 (Media Cybernetics, Inc., Silver Spring, MD, USA) analysis system to indicate the production of ROS, with the data expressed in relative fluorescence units.</p></sec>
<sec>
<title>Immunohistochemistry</title>
<p>Following the morris water maze assessment, the animals (n=10; five rats/group) were sacrificed and the brains were removed. The brains were fixed in 4% paraformaldehyde and embedded in paraffin. The paraffin sections were cut at 5 <italic>&#x000B5;</italic>m and mounted onto glass slides. Prior to immunostaining, the sections were deparaffinized and rehydrated in water. The endogenous peroxidase activity was inhibited by incubation with 0.3% hydrogen peroxide for 30 min. Subsequently, the sections were incubated with normal goat serum at room temperature for 30 min, following which the sections were incubated with primary antibodies overnight at 4&#x000B0;C. The primary rabbit polyclonal antibodies were protein kinase C &#x003B1; (PKC&#x003B1;; BS1577; 1:200; Bioworld Technology, St. Louis Park, MN, USA), p47<italic>phox</italic> (BS4600; 1:200; Bioworld Technology), NOX2 (BS5674; 1:100; Bioworld Technology) and RAC1 (24072-1-AP; 1:100; ProteinTech, Chicago, IL, USA). Immunostaining was visualized using a peroxidase method with an ABC kit (Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China). The sections were resin-mounted and observed under a microscope (Olympus IX71; Olympus). The positive cells were stained brown. A total of five sections in each group were assessed for quantitative analysis and a total of three consecutive fields (magnification, &#x000D7;400) of the cortex, and hippocampal CA1 and CA3 regions, in each section were observed. The mean optical density of the positive neurons of the hippocampal CA1 and CA3 regions and the cortex in each section were measured using the Image-Pro Plus 6.0 analysis system to determine the expression levels of PKC&#x003B1;, p47<italic>phox</italic>, NOX2 and RAC1 (<xref rid="b22-mmr-12-03-4546" ref-type="bibr">22</xref>).</p></sec>
<sec>
<title>Immunoblot analysis</title>
<p>Tissue from the cortex and the hippocampus (100 mg) were homogenized in 1 ml radioimmunoprecipitation assay lysis buffer; Beyotime Institute of Biotechnology). Equal quantities of protein (50 <italic>&#x000B5;</italic>g) were separated using SDS-PAGE and transferred onto polyvinylidene difluoride membranes. The membranes were washed in Tris-buffered saline with Tween 20 (TBS-T) and further incubated with the antibodies against NOX2 (1:500), p47<italic>phox</italic> (1:500), RAC1 (1:500) and &#x003B2;-actin (1:1,000) overnight at 4&#x000B0;C. The membranes were thoroughly washed with TBS-T and then incubated with anti-rabbit immunoglobulin G antibody conjugated to horseradish peroxidase (1:10,000) for 1 h. Following washing with TBS-T, the immunoreactive bands were visualized using an enhanced chemiluminesense kit (Amersham Biosciences, Little Chalfont, UK). The Tanon4500 imaging system (Shanghai Tanon Science &amp; Technology Co., Ltd., Shanghai, China) was used to visualize protein bands, and densitometry was performed using ImageJ software, version 1.43 (National Institutes of Health, Bethesda, MD, USA). The ratio of the target band to that of &#x003B2;-actin was determined to calculate the relative intensity of the expression of p47<italic>phox</italic>, NOX2 and RAC1.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Data are expressed as the mean &#x000B1; standard deviation. The SPSS 17.0 (SPSS, Inc., Chicago, IL, USA) statistical software package was used to analyze the results. Statistical comparisons between groups were performed using Student's t-test with Bonferroni's post hoc test. P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Learning and memory impairments in 16-month-old female rats, determined using a Morris water maze</title>
<p>A Morris water maze assessment was performed to assess the learning and memory skills in the rats, as described above. In the learning and memory training experiments, the mean escape latencies in the 3-and 16-month-old groups on the first day were significantly different (40.02&#x000B1;13.74, vs. 58.89&#x000B1;8.75, respectively; P=0.005). No significant differences were observed in the training experiments between day 2 and day 4 in the 3-month and 16-month-old groups (<xref rid="f1-mmr-12-03-4546" ref-type="fig">Fig. 1A</xref>). In the probe trial experiments (<xref rid="f1-mmr-12-03-4546" ref-type="fig">Fig. 1B</xref>), the swimming distance (14.16&#x000B1;1.56, vs. 11.30&#x000B1;1.90; P=0.007; <xref rid="f1-mmr-12-03-4546" ref-type="fig">Fig. 1C</xref>), mean swimming speed (0.24&#x000B1;0.03, vs. 0.19&#x000B1;0.03; P=0.007; <xref rid="f1-mmr-12-03-4546" ref-type="fig">Fig. 1D</xref>), and the swimming duration and distance to the platform (<xref rid="f1-mmr-12-03-4546" ref-type="fig">Fig. 1E</xref> and <xref rid="f1-mmr-12-03-4546" ref-type="fig">1F</xref>; P=0.006 and P=0.003) were significantly different in the 3-month and 16-month-old groups, respectively. In addition, the number of crossings (3.88&#x000B1;1.55, vs. 2.13&#x000B1;1.3; P=0.035; <xref rid="f1-mmr-12-03-4546" ref-type="fig">Fig. 1G</xref>) and the time of first entry onto the platform (13.71&#x000B1;12.76, vs. 35.01&#x000B1;17.74; P=0.02; <xref rid="f1-mmr-12-03-4546" ref-type="fig">Fig. 1H</xref>) in the 3-month and 16-month-old groups, respectively were significantly different.</p></sec>
<sec>
<title>Levels of serum estradiol and LH in the 16-month-old rats</title>
<p>Levels of estradiol, which decline during the menopause have been associated with learning and memory impairments (<xref rid="b28-mmr-12-03-4546" ref-type="bibr">28</xref>,<xref rid="b29-mmr-12-03-4546" ref-type="bibr">29</xref>). To investigate the possible links between memory impairments in the menopause and the levels of serum estradiol and LH, the levels of serum estradiol and LH in the 3-month and 16-month-old rats were examined. The results revealed that, compared with the 3-month-old rats, the level of serum estradiol was significantly decreased in the 16-month-old rats (137.86&#x000B1;26.10, vs. 91.15&#x000B1;25.99, respectively; P=0.0008; <xref rid="f2-mmr-12-03-4546" ref-type="fig">Fig. 2A</xref>). No significant differences were identified in the level of serum LH between the 3-month and 16-month-old rats (<xref rid="f2-mmr-12-03-4546" ref-type="fig">Fig. 2B</xref>).</p></sec>
<sec>
<title>Activity of SOD and the level of MDA in the brain tissues</title>
<p>Compared with the 3-month-old group, the SOD activity was significantly decreased (P=0.03) and the MDA content was significantly increased (P=0.009) in the 16-month-old rats (<xref rid="f3-mmr-12-03-4546" ref-type="fig">Fig. 3</xref>).</p></sec>
<sec>
<title>ROS production in the frontal cortex and hippocampal CA1 and CA3 regions in 16-month old female rats</title>
<p>DHE was used to detect the production of ROS in the cortex and hippocampal CA1 and CA3 regions in the 3-month and 16-month-old rats (<xref rid="b27-mmr-12-03-4546" ref-type="bibr">27</xref>). A low level of fluorescence was detected in the cortex and hippocampal CA1 and CA3 regions in the 3-month rats (<xref rid="f4-mmr-12-03-4546" ref-type="fig">Fig. 4A</xref>), indicating mild ROS production. However, in the 16-month-old group, the production of ROS was significantly increased in the cortex and hippocampal CA1 and CA3 regions (<xref rid="f4-mmr-12-03-4546" ref-type="fig">Fig. 4A</xref> and <xref rid="f4-mmr-12-03-4546" ref-type="fig">4B</xref>; P=0.001, P=0.024 and P=0.009, respectively).</p></sec>
<sec>
<title>Expression levels of PKC&#x003B1;, NOX2, p47phox and RAC1 in the frontal cortex and hippocampus in 16-month-old rats</title>
<p>NOX family members are important sources for the generation of ROS in neurodegenerative diseases. Therefore, the expression levels of PKC&#x003B1;, which activates NOX2, the NOX2 membrane subunit, the p47<italic>phox</italic> cytosolic subunit and RAC1 were investigated in the frontal cortex and hippocampal CA1 and CA3 regions using immunohistochemistry. The PKC&#x003B1; immunostaining results revealed that the expression of PKC&#x003B1; was significantly increased in the cortex and the hippocampal CA1 and CA3 regions in the 16-month-old group (<xref rid="f5-mmr-12-03-4546" ref-type="fig">Fig. 5A</xref> and <xref rid="f5-mmr-12-03-4546" ref-type="fig">5B</xref>; P&lt;0.05). The NOX2 immunostaining results revealed lower expression levels of NOX2 in the cortex and the hippocampal CA1 and CA3 regions in the 3-month-old rats, as the immunoreactive staining was light. Compared with the 3-month old group, the numbers of NOX2 immunoreactive cells were significantly increased in the cortex and the hippocampal CA1 and CA3 regions in the 16-month-old rats, in which staining was marked (<xref rid="f5-mmr-12-03-4546" ref-type="fig">Fig. 5C</xref> and <xref rid="f5-mmr-12-03-4546" ref-type="fig">5D</xref>; P&lt;0.05). The p47<italic>phox</italic> and RAC1 immunostaining results also revealed that the p47<italic>phox</italic> cytosolic subunit and RAC1, particularly p47<italic>phox</italic>, were expressed in the cortex and hippocampus in the two groups. However, compared with the 3-month group, the expression levels of p47<italic>phox</italic> and RAC1, particularly p47<italic>phox</italic>, were significantly increased in the cortex and the hippocampal CA1 and CA3 regions in the 16-month old female rats (<xref rid="f5-mmr-12-03-4546" ref-type="fig">Fig. 5E</xref> and <xref rid="f5-mmr-12-03-4546" ref-type="fig">5F</xref>; P&lt;0.05 and P&lt;0.01 for p47<italic>phox</italic>; <xref rid="f5-mmr-12-03-4546" ref-type="fig">Fig. 5G</xref> and <xref rid="f5-mmr-12-03-4546" ref-type="fig">5H</xref>; P&lt;0.05 for RAC1).</p>
<p>The expression levels of NOX2, p47<italic>phox</italic> and RAC1 were also assessed in the frontal cortex and the hippocampus using immunoblotting (<xref rid="f6-mmr-12-03-4546" ref-type="fig">Fig. 6A</xref>). The results revealed that the expression levels of NOX2, p47<italic>phox</italic> and RAC1 were also significantly increased in the 16-month-old rats (<xref rid="f6-mmr-12-03-4546" ref-type="fig">Fig. 6B</xref>; P&lt;0.05).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In the present study, menopause-associated differences in learning and memory ability, levels of serum estradiol and LH, and NADPH oxidase-derived ROS production were examined in the frontal cortex and hippocampal CA1 and CA3 regions of 3-month and 16-month-old female rats. The natural menopause is characterized by a progressive decline in the levels of estrogen and is often accompanied by locomotor decline with age (<xref rid="b8-mmr-12-03-4546" ref-type="bibr">8</xref>,<xref rid="b28-mmr-12-03-4546" ref-type="bibr">28</xref>,<xref rid="b30-mmr-12-03-4546" ref-type="bibr">30</xref>). Numerous studies have demonstrated that there are significant learning and memory impairments in females undergoing surgical or natural menopause and in adult ovariectomized female rats and mice (<xref rid="b4-mmr-12-03-4546" ref-type="bibr">4</xref>,<xref rid="b5-mmr-12-03-4546" ref-type="bibr">5</xref>,<xref rid="b31-mmr-12-03-4546" ref-type="bibr">31</xref>,<xref rid="b32-mmr-12-03-4546" ref-type="bibr">32</xref>). In addition, estrogen levels can affect learning and memory, inducing impairments in spatial reference memory, spatial working memory and non-spatial memory, in aging and adult rodents (<xref rid="b3-mmr-12-03-4546" ref-type="bibr">3</xref>,<xref rid="b31-mmr-12-03-4546" ref-type="bibr">31</xref>&#x02013;<xref rid="b33-mmr-12-03-4546" ref-type="bibr">33</xref>). The present study revealed that learning and memory abilities were significantly decreased in the 16-month-old female rats. In addition, the level of serum estradiol was found to be significantly decreased in the 16-month-old rats. These results were consistent with those of previous studies (<xref rid="b3-mmr-12-03-4546" ref-type="bibr">3</xref>,<xref rid="b31-mmr-12-03-4546" ref-type="bibr">31</xref>&#x02013;<xref rid="b33-mmr-12-03-4546" ref-type="bibr">33</xref>). However, these changes are also associated with age and further studies are required to elucidate the association between menopause and age-associated learning and memory impairments.</p>
<p>In 1956, Harman (<xref rid="b34-mmr-12-03-4546" ref-type="bibr">34</xref>) introduced the free radical theory of aging, suggesting that constitutively produced ROS interact with cellular components in a cumulatively deleterious manner. Subsequent studies have demonstrated that ROS are central in the pathogenesis of several diseases, including cardiovascular disease, kidney damage and neurodegenerative diseases (<xref rid="b35-mmr-12-03-4546" ref-type="bibr">35</xref>&#x02013;<xref rid="b37-mmr-12-03-4546" ref-type="bibr">37</xref>). The cortex and the hippocampus are important brain areas, involved in the process of learning and memory. Whether ROS levels in the cortex and the hippocampus are involved in the modulation of learning and spatial memory decline in the menopause remains to be elucidated. In the present study, the activity of SOD, the level of MDA and the production of ROS were examined in the cortex and hippocampus of 3-month and 16-month-old rats. The results revealed that the activity of SOD was decreased and the content of MDA was increased in the brain tissues of the 16-month-old rats. ROS production was also increased significantly in the cortex and the hippocampal CA1 and CA3 regions in the 16-month-old female rats. These data suggested that the accumulation of ROS in the cortex and the hippocampus was important in the modulation of learning and memory impairments in the menopause.</p>
<p>There is increasing evidence that NOX family members are important sources of ROS in neurodegenerative diseases (<xref rid="b38-mmr-12-03-4546" ref-type="bibr">38</xref>,<xref rid="b39-mmr-12-03-4546" ref-type="bibr">39</xref>). Previous studies have reported a correlation between NOX activity and the progression of Alzheimer's disease, suggesting that increased NADPH oxidase activity may be one of the early events in the transition from normal cognition to dementia (<xref rid="b18-mmr-12-03-4546" ref-type="bibr">18</xref>,<xref rid="b40-mmr-12-03-4546" ref-type="bibr">40</xref>,<xref rid="b41-mmr-12-03-4546" ref-type="bibr">41</xref>). Furthermore, the increased expression of NOX4 in human renin/angiotensinogen chimeric transgenic mice is associated with increased NOX activity and cognitive decline (<xref rid="b42-mmr-12-03-4546" ref-type="bibr">42</xref>). In addition, NOX activity is also significantly increased in aged amyloid precursor protein/presinilin 1 mice, and shares a significant linear correlation with deficits in cognitive function (<xref rid="b17-mmr-12-03-4546" ref-type="bibr">17</xref>). However, whether NOX-mediated ROS accumulation is involved in the cognitive impairments in the menopause remains to be elucidated.</p>
<p>NOX, which is dedicated to the specific production of ROS, consists of membrane (gp91<italic>phox</italic>, also termed NOX2 and p22<italic>phox</italic>) and cytosolic (p47<italic>phox</italic>, p67<italic>phox</italic>, p40<italic>phox</italic> and RAC1) components (<xref rid="b43-mmr-12-03-4546" ref-type="bibr">43</xref>,<xref rid="b44-mmr-12-03-4546" ref-type="bibr">44</xref>). The NOX2 membrane-integrated protein is the catalytic core of the enzyme responsible for electron transfer between NADPH and molecular oxygen for superoxide production. In nonphagocytic cells, NOX is constitutively activated, producing relatively low levels of ROS under basal conditions and generating higher levels of ROS in response to cytokines and growth factors. The increased ROS accumulation can result in the stimulation of redox-sensitive intracellular signaling pathways (<xref rid="b45-mmr-12-03-4546" ref-type="bibr">45</xref>). Previous studies have revealed that PKC can phosphorylate the gp91<italic>phox</italic>-cytosolic tail, and phosphorylation of gp91<italic>phox</italic> enhances the catalytic activity and assembly of the complex (<xref rid="b46-mmr-12-03-4546" ref-type="bibr">46</xref>). Upon activation, the cytosolic components translocate to the membrane, as a result of interactions between the cytosolic components and its phospholipid environment (<xref rid="b47-mmr-12-03-4546" ref-type="bibr">47</xref>). A previous study demonstrated that the elevated expression of p47phox was confirmed as NOX activation (<xref rid="b48-mmr-12-03-4546" ref-type="bibr">48</xref>). In the present study, the immunohistochemistry results revealed that the expression levels of PKC&#x003B1;, NOX2, p47<italic>phox</italic> and RAC1 were significantly increased in the cortex and the hippocampus of 16-month-old female rats, compared with 3-month-old rats. The immunoblotting results also demonstrated that the expression levels of NOX2, p47<italic>phox</italic> and RAC1 were significantly increased in the 16-month-old female rats. These data suggested that NOX-derived ROS accumulation in the frontal cortex and hippocampus may be involved in cognitive impairments in 16-month-old female rats.</p>
<p>In conclusion, the present study demonstrated that NOX-derived ROS accumulation may be involved in menopause-associated learning and memory impairments. Although the present study provided an experimental basis for the mechanism of NOX-derived ROS accumulation and learning and memory impairments in 16 month old female rats, further investigations are required to elucidate the mechanisms underlying menopause-associated learning and memory impairments.</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This study was supported by the National Natural Science Foundation of China (grant no. 81371329), the Nature Science Foundation of Anhui Province (grant. no. 1308085MH144) and the Doctor Foundation of Anhui Medical University (grant no. XJ201011). The authors would like to thank Mr. Shan Huang and Mrs. Li Gui from the Synthetic Laboratory of Basic Medicine College, Anhui Medical University for their technical assistance.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-12-03-4546"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greendale</surname><given-names>GA</given-names></name><name><surname>Lee</surname><given-names>NP</given-names></name><name><surname>Arriola</surname><given-names>ER</given-names></name></person-group><article-title>The menopause</article-title><source>Lancet</source><volume>353</volume><fpage>571</fpage><lpage>580</lpage><year>1999</year><pub-id pub-id-type="doi">10.1016/S0140-6736(98)05352-5</pub-id><pub-id pub-id-type="pmid">10028999</pub-id></element-citation></ref>
<ref id="b2-mmr-12-03-4546"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan Mitchell</surname><given-names>E</given-names></name><name><surname>Fugate Woods</surname><given-names>N</given-names></name></person-group><article-title>Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study</article-title><source>J Womens Health Gend Based Med</source><volume>10</volume><fpage>351</fpage><lpage>362</lpage><year>2001</year><pub-id pub-id-type="doi">10.1089/152460901750269670</pub-id><pub-id pub-id-type="pmid">11445026</pub-id></element-citation></ref>
<ref id="b3-mmr-12-03-4546"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherwin</surname><given-names>BB</given-names></name></person-group><article-title>Surgical menopause, estrogen and cognitive function in women: what do the findings tell us?</article-title><source>Ann NY Acad Sci</source><volume>1052</volume><fpage>3</fpage><lpage>10</lpage><year>2005</year><pub-id pub-id-type="doi">10.1196/annals.1347.001</pub-id></element-citation></ref>
<ref id="b4-mmr-12-03-4546"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>VW</given-names></name><name><surname>Popat</surname><given-names>RA</given-names></name></person-group><article-title>Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions</article-title><source>Neuroscience</source><volume>191</volume><fpage>129</fpage><lpage>138</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.05.059</pub-id><pub-id pub-id-type="pmid">21664950</pub-id></element-citation></ref>
<ref id="b5-mmr-12-03-4546"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luine</surname><given-names>VN</given-names></name><name><surname>Richards</surname><given-names>ST</given-names></name><name><surname>Wu</surname><given-names>VY</given-names></name><name><surname>Beck</surname><given-names>KD</given-names></name></person-group><article-title>Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters</article-title><source>Horm Behav</source><volume>34</volume><fpage>149</fpage><lpage>162</lpage><year>1998</year><pub-id pub-id-type="doi">10.1006/hbeh.1998.1473</pub-id><pub-id pub-id-type="pmid">9799625</pub-id></element-citation></ref>
<ref id="b6-mmr-12-03-4546"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frick</surname><given-names>KM</given-names></name><name><surname>Fernandez</surname><given-names>SM</given-names></name><name><surname>Bulinski</surname><given-names>SC</given-names></name></person-group><article-title>Estrogen replacement improves spatial reference memory and increases hippocampal synaptophysin in aged female mice</article-title><source>Neuroscience</source><volume>115</volume><fpage>547</fpage><lpage>558</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0306-4522(02)00377-9</pub-id><pub-id pub-id-type="pmid">12421621</pub-id></element-citation></ref>
<ref id="b7-mmr-12-03-4546"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocca</surname><given-names>WA</given-names></name><name><surname>Bower</surname><given-names>JH</given-names></name><name><surname>Maraganore</surname><given-names>DM</given-names></name><name><surname>Ahlskog</surname><given-names>JE</given-names></name><name><surname>Grossardt</surname><given-names>BR</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names></name></person-group><article-title>Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause</article-title><source>Neurology</source><volume>69</volume><fpage>1074</fpage><lpage>1083</lpage><year>2007</year><pub-id pub-id-type="doi">10.1212/01.wnl.0000276984.19542.e6</pub-id><pub-id pub-id-type="pmid">17761551</pub-id></element-citation></ref>
<ref id="b8-mmr-12-03-4546"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manly</surname><given-names>JJ</given-names></name><name><surname>Merchant</surname><given-names>CA</given-names></name><name><surname>Jacobs</surname><given-names>DM</given-names></name><name><surname>Small</surname><given-names>SA</given-names></name><name><surname>Bell</surname><given-names>K</given-names></name><name><surname>Ferin</surname><given-names>M</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name></person-group><article-title>Endogenous estrogen levels and Alzheimer's disease among postmenopausal women</article-title><source>Neurology</source><volume>54</volume><fpage>833</fpage><lpage>837</lpage><year>2000</year><pub-id pub-id-type="doi">10.1212/WNL.54.4.833</pub-id><pub-id pub-id-type="pmid">10690972</pub-id></element-citation></ref>
<ref id="b9-mmr-12-03-4546"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>SM</given-names></name><name><surname>Sherwin</surname><given-names>BB</given-names></name></person-group><article-title>Effects of estrogen on memory function in surgically menopausal women</article-title><source>Psychoneuroendocrinology</source><volume>17</volume><fpage>485</fpage><lpage>495</lpage><year>1992</year><pub-id pub-id-type="doi">10.1016/0306-4530(92)90007-T</pub-id><pub-id pub-id-type="pmid">1484915</pub-id></element-citation></ref>
<ref id="b10-mmr-12-03-4546"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CC</given-names></name><name><surname>Vedder</surname><given-names>LC</given-names></name><name><surname>Nelson</surname><given-names>AR</given-names></name><name><surname>Bredemann</surname><given-names>TM</given-names></name><name><surname>McMahon</surname><given-names>LL</given-names></name></person-group><article-title>Duration of estrogen deprivation, not chronological age, prevents estrogen's ability to enhance hippocampal synaptic physiology</article-title><source>Proc Natl Acad Sci USA</source><volume>107</volume><fpage>19543</fpage><lpage>19548</lpage><year>2010</year><pub-id pub-id-type="doi">10.1073/pnas.1009307107</pub-id><pub-id pub-id-type="pmid">20974957</pub-id><pub-id pub-id-type="pmcid">2984203</pub-id></element-citation></ref>
<ref id="b11-mmr-12-03-4546"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>MA</given-names></name><name><surname>Scheff</surname><given-names>SW</given-names></name></person-group><article-title>Oxidative stress in the progression of Alzheimer disease in the frontal cortex</article-title><source>J Neuropathol Exp Neurol</source><volume>69</volume><fpage>155</fpage><lpage>167</lpage><year>2010</year><pub-id pub-id-type="doi">10.1097/NEN.0b013e3181cb5af4</pub-id><pub-id pub-id-type="pmid">20084018</pub-id><pub-id pub-id-type="pmcid">2826839</pub-id></element-citation></ref>
<ref id="b12-mmr-12-03-4546"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>JN</given-names></name><name><surname>Schmitt</surname><given-names>FA</given-names></name><name><surname>Scheff</surname><given-names>SW</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Butterfield</surname><given-names>DA</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name></person-group><article-title>Evidence of increased oxidative damage in subjects with mild cognitive impairment</article-title><source>Neurology</source><volume>64</volume><fpage>1152</fpage><lpage>1156</lpage><year>2005</year><pub-id pub-id-type="doi">10.1212/01.WNL.0000156156.13641.BA</pub-id><pub-id pub-id-type="pmid">15824339</pub-id></element-citation></ref>
<ref id="b13-mmr-12-03-4546"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Pei</surname><given-names>Z</given-names></name><name><surname>Miller</surname><given-names>DS</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Block</surname><given-names>ML</given-names></name><name><surname>Wilson</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Hong</surname><given-names>JS</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease</article-title><source>FASEB J</source><volume>19</volume><fpage>533</fpage><lpage>542</lpage><year>2005</year><pub-id pub-id-type="doi">10.1096/fj.04-2751com</pub-id><pub-id pub-id-type="pmid">15791003</pub-id></element-citation></ref>
<ref id="b14-mmr-12-03-4546"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutowicz</surname><given-names>M</given-names></name></person-group><article-title>The influence of reactive oxygen species on the central nervous system</article-title><source>Postepy Hig Med Dosw</source><volume>65</volume><fpage>104</fpage><lpage>113</lpage><year>2011</year><comment>In Polish</comment><pub-id pub-id-type="doi">10.5604/17322693.933486</pub-id></element-citation></ref>
<ref id="b15-mmr-12-03-4546"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Serrano</surname><given-names>F</given-names></name><name><surname>Oury</surname><given-names>TD</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><article-title>Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase</article-title><source>J Neurosci</source><volume>26</volume><fpage>3933</fpage><lpage>3941</lpage><year>2006</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5566-05.2006</pub-id><pub-id pub-id-type="pmid">16611809</pub-id></element-citation></ref>
<ref id="b16-mmr-12-03-4546"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x000F6;ge</surname><given-names>W</given-names></name></person-group><article-title>Free radicals in the physiological control of cell function</article-title><source>Physiol Rev</source><volume>82</volume><fpage>47</fpage><lpage>95</lpage><year>2002</year><pub-id pub-id-type="doi">10.1152/physrev.00018.2001</pub-id><pub-id pub-id-type="pmid">11773609</pub-id></element-citation></ref>
<ref id="b17-mmr-12-03-4546"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce-Keller</surname><given-names>AJ</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Knight</surname><given-names>AG</given-names></name><name><surname>Beckett</surname><given-names>TL</given-names></name><name><surname>McMullen</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>PR</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name><name><surname>Van Eldik</surname><given-names>LJ</given-names></name><name><surname>St Clair</surname><given-names>D</given-names></name><name><surname>Keller</surname><given-names>JN</given-names></name></person-group><article-title>Cognitive impairment in humanized APPxPS1 mice is linked to A&#x003B2;(1&#x02013;42) and NOX activation</article-title><source>Neurobiol Dis</source><volume>44</volume><fpage>317</fpage><lpage>326</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.nbd.2011.07.012</pub-id></element-citation></ref>
<ref id="b18-mmr-12-03-4546"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>MA</given-names></name><name><surname>Scheff</surname><given-names>SW</given-names></name></person-group><article-title>NADPH-oxidase activation and cognition in Alzheimer disease progression</article-title><source>Free Radic Biol Med</source><volume>51</volume><fpage>171</fpage><lpage>178</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.03.025</pub-id><pub-id pub-id-type="pmid">21457777</pub-id><pub-id pub-id-type="pmcid">3109185</pub-id></element-citation></ref>
<ref id="b19-mmr-12-03-4546"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorce</surname><given-names>S</given-names></name><name><surname>Krause</surname><given-names>KH</given-names></name></person-group><article-title>NOX enzymes in the central nervous system: from signaling to disease</article-title><source>Antioxid Redox Signal</source><volume>11</volume><fpage>2481</fpage><lpage>2504</lpage><year>2009</year><pub-id pub-id-type="doi">10.1089/ars.2009.2578</pub-id><pub-id pub-id-type="pmid">19309263</pub-id></element-citation></ref>
<ref id="b20-mmr-12-03-4546"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tejada-Simon</surname><given-names>MV</given-names></name><name><surname>Serrano</surname><given-names>F</given-names></name><name><surname>Villasana</surname><given-names>LE</given-names></name><name><surname>Kanterewicz</surname><given-names>BI</given-names></name><name><surname>Wu</surname><given-names>GY</given-names></name><name><surname>Quinn</surname><given-names>MT</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><article-title>Synaptic localization of a functional NADPH oxidase in the mouse hippocampus</article-title><source>Mol Cell Neurosci</source><volume>29</volume><fpage>97</fpage><lpage>106</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.mcn.2005.01.007</pub-id><pub-id pub-id-type="pmid">15866050</pub-id><pub-id pub-id-type="pmcid">2013304</pub-id></element-citation></ref>
<ref id="b21-mmr-12-03-4546"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Feng</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name></person-group><article-title>Selection of nutrients for prevention or amelioration of lead-induced learning and memory impairment in rats</article-title><source>Ann Occup Hyg</source><volume>53</volume><fpage>341</fpage><lpage>351</lpage><year>2009</year><pub-id pub-id-type="doi">10.1093/annhyg/mep019</pub-id><pub-id pub-id-type="pmid">19357318</pub-id></element-citation></ref>
<ref id="b22-mmr-12-03-4546"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>WZ</given-names></name><name><surname>Li</surname><given-names>WP</given-names></name><name><surname>Huang</surname><given-names>DK</given-names></name><name><surname>Kan</surname><given-names>HW</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>WY</given-names></name><name><surname>Yin</surname><given-names>YY</given-names></name><name><surname>Yao</surname><given-names>YY</given-names></name></person-group><article-title>Dexamethasone and A&#x003B2;<sub>25&#x02013;35</sub> accelerate learning and memory impairments due to elevate amyloid precursor protein expression and neuronal apoptosis in 12-month male rats</article-title><source>Behav Brain Res</source><volume>227</volume><fpage>142</fpage><lpage>149</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bbr.2011.10.038</pub-id></element-citation></ref>
<ref id="b23-mmr-12-03-4546"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Swift</surname><given-names>TA</given-names></name><name><surname>West</surname><given-names>CA</given-names></name><name><surname>Rosano</surname><given-names>TG</given-names></name><name><surname>Rej</surname><given-names>R</given-names></name></person-group><article-title>Immunoassay of estradiol: unanticipated suppression by unconjugated estriol</article-title><source>Clin Chem</source><volume>50</volume><fpage>160</fpage><lpage>165</lpage><year>2004</year><pub-id pub-id-type="doi">10.1373/clinchem.2003.023325</pub-id><pub-id pub-id-type="pmid">14709643</pub-id></element-citation></ref>
<ref id="b24-mmr-12-03-4546"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joffe</surname><given-names>H</given-names></name><name><surname>Petrillo</surname><given-names>LF</given-names></name><name><surname>Koukopoulos</surname><given-names>A</given-names></name><name><surname>Viguera</surname><given-names>AC</given-names></name><name><surname>Hirschberg</surname><given-names>A</given-names></name><name><surname>Nonacs</surname><given-names>R</given-names></name><name><surname>Somley</surname><given-names>B</given-names></name><name><surname>Pasciullo</surname><given-names>E</given-names></name><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Cohen</surname><given-names>LS</given-names></name></person-group><article-title>Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition</article-title><source>J Clin Endocrinol Metab</source><volume>96</volume><fpage>E1044</fpage><lpage>E1054</lpage><year>2011</year><pub-id pub-id-type="doi">10.1210/jc.2010-2503</pub-id><pub-id pub-id-type="pmid">21525161</pub-id><pub-id pub-id-type="pmcid">3135198</pub-id></element-citation></ref>
<ref id="b25-mmr-12-03-4546"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girouard</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>L</given-names></name><name><surname>Anrather</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Iadecola</surname><given-names>C</given-names></name></person-group><article-title>Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>27</volume><fpage>303</fpage><lpage>309</lpage><year>2007</year><pub-id pub-id-type="doi">10.1161/01.ATV.0000253885.41509.25</pub-id></element-citation></ref>
<ref id="b26-mmr-12-03-4546"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikalov</surname><given-names>S</given-names></name><name><surname>Griendling</surname><given-names>KK</given-names></name><name><surname>Harrison</surname><given-names>DG</given-names></name></person-group><article-title>Measurement of reactive oxygen species in cardiovascular studies</article-title><source>Hypertension</source><volume>49</volume><fpage>717</fpage><lpage>727</lpage><year>2007</year><pub-id pub-id-type="doi">10.1161/01.HYP.0000258594.87211.6b</pub-id><pub-id pub-id-type="pmid">17296874</pub-id><pub-id pub-id-type="pmcid">1993891</pub-id></element-citation></ref>
<ref id="b27-mmr-12-03-4546"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girouard</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Gallo</surname><given-names>EF</given-names></name><name><surname>Anrather</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Pickel</surname><given-names>VM</given-names></name><name><surname>Iadecola</surname><given-names>C</given-names></name></person-group><article-title>NMDA receptor activation increases free radical production through nitric oxide and NOX2</article-title><source>J Neurosci</source><volume>29</volume><fpage>2545</fpage><lpage>2552</lpage><year>2009</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0133-09.2009</pub-id><pub-id pub-id-type="pmid">19244529</pub-id><pub-id pub-id-type="pmcid">2669930</pub-id></element-citation></ref>
<ref id="b28-mmr-12-03-4546"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedden</surname><given-names>T</given-names></name><name><surname>Gabrieli</surname><given-names>JD</given-names></name></person-group><article-title>Insights into the ageing mind: a view from cognitive neuroscience</article-title><source>Nat Rev Neurosci</source><volume>5</volume><fpage>87</fpage><lpage>96</lpage><year>2004</year><pub-id pub-id-type="doi">10.1038/nrn1323</pub-id><pub-id pub-id-type="pmid">14735112</pub-id></element-citation></ref>
<ref id="b29-mmr-12-03-4546"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>IA</given-names></name><name><surname>Gallagher</surname><given-names>M</given-names></name><name><surname>Eichenbaum</surname><given-names>H</given-names></name><name><surname>Tanila</surname><given-names>H</given-names></name></person-group><article-title>Neurocognitive aging: prior memories hinder new hippocampal encoding</article-title><source>Trends Neurosci</source><volume>29</volume><fpage>662</fpage><lpage>670</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.tins.2006.10.002</pub-id><pub-id pub-id-type="pmid">17046075</pub-id><pub-id pub-id-type="pmcid">2614702</pub-id></element-citation></ref>
<ref id="b30-mmr-12-03-4546"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondratova</surname><given-names>AA</given-names></name><name><surname>Kondratov</surname><given-names>RV</given-names></name></person-group><article-title>The circadian clock and pathology of the ageing brain</article-title><source>Nat Rev Neurosci</source><volume>13</volume><fpage>325</fpage><lpage>335</lpage><year>2012</year><pub-id pub-id-type="pmid">22395806</pub-id><pub-id pub-id-type="pmcid">3718301</pub-id></element-citation></ref>
<ref id="b31-mmr-12-03-4546"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>JM</given-names></name><name><surname>Hulst</surname><given-names>JL</given-names></name><name><surname>Berbling</surname><given-names>JL</given-names></name></person-group><article-title>Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation</article-title><source>Endocrinology</source><volume>147</volume><fpage>607</fpage><lpage>614</lpage><year>2006</year><pub-id pub-id-type="doi">10.1210/en.2005-0998</pub-id></element-citation></ref>
<ref id="b32-mmr-12-03-4546"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duff</surname><given-names>SJ</given-names></name><name><surname>Hampson</surname><given-names>E</given-names></name></person-group><article-title>A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy</article-title><source>Horm Behav</source><volume>38</volume><fpage>262</fpage><lpage>276</lpage><year>2000</year><pub-id pub-id-type="doi">10.1006/hbeh.2000.1625</pub-id><pub-id pub-id-type="pmid">11104644</pub-id></element-citation></ref>
<ref id="b33-mmr-12-03-4546"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>RB</given-names></name></person-group><article-title>Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats</article-title><source>Neurobiol Aging</source><volume>21</volume><fpage>107</fpage><lpage>116</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0197-4580(00)00103-2</pub-id><pub-id pub-id-type="pmid">10794855</pub-id></element-citation></ref>
<ref id="b34-mmr-12-03-4546"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>D</given-names></name></person-group><article-title>Aging: a theory based on free radical and radiation chemistry</article-title><source>J Gerontol</source><volume>11</volume><fpage>298</fpage><lpage>300</lpage><year>1956</year><pub-id pub-id-type="doi">10.1093/geronj/11.3.298</pub-id><pub-id pub-id-type="pmid">13332224</pub-id></element-citation></ref>
<ref id="b35-mmr-12-03-4546"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>KE</given-names></name><name><surname>Aschner</surname><given-names>JL</given-names></name><name><surname>Milatovic</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>JW</given-names></name><name><surname>Aschner</surname><given-names>M</given-names></name><name><surname>Kaplowitz</surname><given-names>MR</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Fike</surname><given-names>CD</given-names></name></person-group><article-title>NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>297</volume><fpage>L596</fpage><lpage>L607</lpage><year>2009</year><pub-id pub-id-type="doi">10.1152/ajplung.90568.2008</pub-id><pub-id pub-id-type="pmid">19592458</pub-id><pub-id pub-id-type="pmcid">2770786</pub-id></element-citation></ref>
<ref id="b36-mmr-12-03-4546"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loukogeorgakis</surname><given-names>SP</given-names></name><name><surname>van den Berg</surname><given-names>MJ</given-names></name><name><surname>Sofat</surname><given-names>R</given-names></name><name><surname>Nitsch</surname><given-names>D</given-names></name><name><surname>Charakida</surname><given-names>M</given-names></name><name><surname>Haiyee</surname><given-names>B</given-names></name><name><surname>de Groot</surname><given-names>E</given-names></name><name><surname>MacAllister</surname><given-names>RJ</given-names></name><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Deanfield</surname><given-names>JE</given-names></name></person-group><article-title>Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans</article-title><source>Circulation</source><volume>121</volume><fpage>2310</fpage><lpage>2316</lpage><year>2010</year><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.814731</pub-id><pub-id pub-id-type="pmid">20479156</pub-id></element-citation></ref>
<ref id="b37-mmr-12-03-4546"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perianayagam</surname><given-names>MC</given-names></name><name><surname>Liangos</surname><given-names>O</given-names></name><name><surname>Kolyada</surname><given-names>AY</given-names></name><name><surname>Wald</surname><given-names>R</given-names></name><name><surname>MacKinnon</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Rao</surname><given-names>M</given-names></name><name><surname>Balakrishnan</surname><given-names>VS</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Pereira</surname><given-names>BJ</given-names></name><name><surname>Jaber</surname><given-names>BL</given-names></name></person-group><article-title>NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure</article-title><source>J Am Soc Nephrol</source><volume>18</volume><fpage>255</fpage><lpage>263</lpage><year>2007</year><pub-id pub-id-type="doi">10.1681/ASN.2006070806</pub-id></element-citation></ref>
<ref id="b38-mmr-12-03-4546"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>KW</given-names></name><name><surname>Baik</surname><given-names>HH</given-names></name><name><surname>Jin</surname><given-names>BK</given-names></name></person-group><article-title>IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo</article-title><source>J Immunol</source><volume>183</volume><fpage>4666</fpage><lpage>4674</lpage><year>2009</year><pub-id pub-id-type="doi">10.4049/jimmunol.0803392</pub-id><pub-id pub-id-type="pmid">19752235</pub-id></element-citation></ref>
<ref id="b39-mmr-12-03-4546"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>QG</given-names></name><name><surname>Raz</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Han</surname><given-names>D</given-names></name><name><surname>De Sevilla</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Vadlamudi</surname><given-names>RK</given-names></name><name><surname>Brann</surname><given-names>DW</given-names></name></person-group><article-title>Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation</article-title><source>J Neurosci</source><volume>29</volume><fpage>13823</fpage><lpage>13836</lpage><year>2009</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3574-09.2009</pub-id><pub-id pub-id-type="pmid">19889994</pub-id><pub-id pub-id-type="pmcid">2807671</pub-id></element-citation></ref>
<ref id="b40-mmr-12-03-4546"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce-Keller</surname><given-names>AJ</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Parrino</surname><given-names>TE</given-names></name><name><surname>Knight</surname><given-names>AG</given-names></name><name><surname>Ebenezer</surname><given-names>PJ</given-names></name><name><surname>Weidner</surname><given-names>AM</given-names></name><name><surname>LeVine</surname><given-names>H</given-names></name><name><surname>Keller</surname><given-names>JN</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name></person-group><article-title>NOX activity is increased in mild cognitive impairment</article-title><source>Antioxid Redox Signal</source><volume>12</volume><fpage>1371</fpage><lpage>1382</lpage><year>2010</year><pub-id pub-id-type="doi">10.1089/ars.2009.2823</pub-id><pub-id pub-id-type="pmcid">2864654</pub-id></element-citation></ref>
<ref id="b41-mmr-12-03-4546"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Monte</surname><given-names>SM</given-names></name><name><surname>Wands</surname><given-names>JR</given-names></name></person-group><article-title>Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease</article-title><source>J Alzheimers Dis</source><volume>9</volume><fpage>167</fpage><lpage>181</lpage><year>2006</year><pub-id pub-id-type="pmid">16873964</pub-id></element-citation></ref>
<ref id="b42-mmr-12-03-4546"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inaba</surname><given-names>S</given-names></name><name><surname>Iwai</surname><given-names>M</given-names></name><name><surname>Furuno</surname><given-names>M</given-names></name><name><surname>Tomono</surname><given-names>Y</given-names></name><name><surname>Kanno</surname><given-names>H</given-names></name><name><surname>Senba</surname><given-names>I</given-names></name><name><surname>Okayama</surname><given-names>H</given-names></name><name><surname>Mogi</surname><given-names>M</given-names></name><name><surname>Higaki</surname><given-names>J</given-names></name><name><surname>Horiuchi</surname><given-names>M</given-names></name></person-group><article-title>Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice</article-title><source>Hypertension</source><volume>53</volume><fpage>356</fpage><lpage>362</lpage><year>2009</year><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.108.123612</pub-id></element-citation></ref>
<ref id="b43-mmr-12-03-4546"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedard</surname><given-names>K</given-names></name><name><surname>Krause</surname><given-names>KH</given-names></name></person-group><article-title>The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology</article-title><source>Physiol Rev</source><volume>87</volume><fpage>245</fpage><lpage>313</lpage><year>2007</year><pub-id pub-id-type="doi">10.1152/physrev.00044.2005</pub-id><pub-id pub-id-type="pmid">17237347</pub-id></element-citation></ref>
<ref id="b44-mmr-12-03-4546"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masamune</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Kikuta</surname><given-names>K</given-names></name><name><surname>Satoh</surname><given-names>K</given-names></name><name><surname>Shimosegawa</surname><given-names>T</given-names></name></person-group><article-title>NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><volume>294</volume><fpage>G99</fpage><lpage>G108</lpage><year>2008</year><pub-id pub-id-type="doi">10.1152/ajpgi.00272.2007</pub-id></element-citation></ref>
<ref id="b45-mmr-12-03-4546"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>NL</given-names></name></person-group><article-title>Nox response to injury</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>22</volume><fpage>4</fpage><lpage>5</lpage><year>2002</year><pub-id pub-id-type="pmid">11788453</pub-id></element-citation></ref>
<ref id="b46-mmr-12-03-4546"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raad</surname><given-names>H</given-names></name><name><surname>Paclet</surname><given-names>MH</given-names></name><name><surname>Boussetta</surname><given-names>T</given-names></name><name><surname>Kroviarski</surname><given-names>Y</given-names></name><name><surname>Morel</surname><given-names>F</given-names></name><name><surname>Quinn</surname><given-names>MT</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>MA</given-names></name><name><surname>Dang</surname><given-names>PM</given-names></name><name><surname>El-Benna</surname><given-names>J</given-names></name></person-group><article-title>Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox and p47phox</article-title><source>FASEB J</source><volume>23</volume><fpage>1011</fpage><lpage>1022</lpage><year>2009</year><pub-id pub-id-type="doi">10.1096/fj.08-114553</pub-id><pub-id pub-id-type="pmcid">2660639</pub-id></element-citation></ref>
<ref id="b47-mmr-12-03-4546"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizrahi</surname><given-names>A</given-names></name><name><surname>Berdichevsky</surname><given-names>Y</given-names></name><name><surname>Casey</surname><given-names>PJ</given-names></name><name><surname>Pick</surname><given-names>E</given-names></name></person-group><article-title>A prenylated p47phox-p67phox-Rac1 chimera is a Quintessential NADPH oxidase activator: membrane association and functional capacity</article-title><source>J Biol Chem</source><volume>285</volume><fpage>25485</fpage><lpage>25499</lpage><year>2010</year><pub-id pub-id-type="doi">10.1074/jbc.M110.113779</pub-id><pub-id pub-id-type="pmid">20529851</pub-id><pub-id pub-id-type="pmcid">2919112</pub-id></element-citation></ref>
<ref id="b48-mmr-12-03-4546"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edlund</surname><given-names>J</given-names></name><name><surname>Fasching</surname><given-names>A</given-names></name><name><surname>Liss</surname><given-names>P</given-names></name><name><surname>Hansell</surname><given-names>P</given-names></name><name><surname>Palm</surname><given-names>F</given-names></name></person-group><article-title>The roles of NADPH-oxidase and nNOS for the increased oxidative stress and the oxygen consumption in the diabetic kidney</article-title><source>Diabetes Metab Res Rev</source><volume>26</volume><fpage>349</fpage><lpage>356</lpage><year>2010</year><pub-id pub-id-type="doi">10.1002/dmrr.1099</pub-id><pub-id pub-id-type="pmid">20583310</pub-id><pub-id pub-id-type="pmcid">2897070</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-mmr-12-03-4546" position="float">
<label>Figure 1</label>
<caption>
<p>Learning and memory abilities of the 3-month and 16-month-old female rats in the Morris water maze task. (A) Learning and memory training experiment over 4 days. (B) Representative path of probe trial experiments on day 5. (C) Swimming distance. (D) Mean swimming speed. (E) Swimming duration in the quadrant of the platform. (F) Distance of the platform in the quadrant. (G) Number of crossings of the platform. (H) Time of first entry onto the platform. Data are expressed as the mean &#x000B1; standard deviation, n=8, <sup>&#x0002A;</sup>P&lt;0.05 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01, vs. 3-month old group.</p></caption>
<graphic xlink:href="MMR-12-03-4546-g00.jpg"/></fig>
<fig id="f2-mmr-12-03-4546" position="float">
<label>Figure 2</label>
<caption>
<p>Levels of plasma estradiol and LH in 3-month and 16-month-old female rats. (A) Level of plasma estradiol. (B) Level of plasma LH. Data are expressed as the mean &#x000B1; standard deviation, n=8, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01, vs 3-month group. LH, luteinizing hormone.</p></caption>
<graphic xlink:href="MMR-12-03-4546-g01.jpg"/></fig>
<fig id="f3-mmr-12-03-4546" position="float">
<label>Figure 3</label>
<caption>
<p>Activity of SOD and the level of MDA in the brain tissue of the 3-month and 16-month-old female rats. (A) Activity of SOD. (B) Level of MDA. Data are expressed as the mean &#x000B1; standard deviation, n=8, <sup>&#x0002A;</sup>P&lt;0.05 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01, vs. 3-month group. MDA, malondialdehyde; SOD, superoxide dismutase.</p></caption>
<graphic xlink:href="MMR-12-03-4546-g02.jpg"/></fig>
<fig id="f4-mmr-12-03-4546" position="float">
<label>Figure 4</label>
<caption>
<p>ROS production in the cortex and hippocampal CA1 and CA3 regions in 3-month and 16-month-old female rats (dihydroethidium fluorescence, magnification, &#x000D7;400). (A) ROS production in the cortex and - hippocampal CA1 and CA3 regions. (B) Quantitative analysis of the ROS production in the cortex and - hippocampal CA1 and CA3 regions. Data are expressed as the mean &#x000B1; standard deviation, n=4, <sup>&#x0002A;</sup>P&lt;0.05 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01, vs. 3-month group. ROS, reactive oxygen species.</p></caption>
<graphic xlink:href="MMR-12-03-4546-g03.jpg"/></fig>
<fig id="f5-mmr-12-03-4546" position="float">
<label>Figure 5</label>
<caption>
<p>Expression levels of PKC&#x003B1;, NOX2, p47phox and RAC1 in the frontal cortex and hippocampal CA1 and CA3 regions in the 3-month and 16-month-old female rats (immunostaining, magnification, &#x000D7;400). The darker areas indicate immunoreactive neurons. (A) Expression of PKC&#x003B1; in the frontal cortex and hippocampal CA1 and CA3 regions. (B) Quantitative analysis of the expression of PKC&#x003B1;. (C) Expression of NOX2 in the frontal cortex and hippocampal CA1 and CA3 regions. (D) Quantitative analysis of the expression of NOX2. (E) Expression of p47phox in the frontal cortex and hippocampal CA1 and CA3 regions. (F) Quantitative analysis of the expression of p47phox. (G) Expression of RAC1 in the frontal cortex and hippocampal CA1 and CA3 regions. (H) Quantitative analysis of the expression of RAC1. Data are expressed as the mean &#x000B1; standard deviation, n=5, <sup>&#x0002A;</sup>P&lt;0.05 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01, vs. 3-month group. PKC&#x003B1;; Protein kinase C &#x003B1;; NOX2, nicotinamide adenine dinucleotide phosphate-oxidase 2; RAC1, Ras-related C3 botulinum toxin substrate 1.</p></caption>
<graphic xlink:href="MMR-12-03-4546-g04.jpg"/></fig>
<fig id="f6-mmr-12-03-4546" position="float">
<label>Figure 6</label>
<caption>
<p>Corresponding densitometry for the expression levels of NOX2, p47<italic>phox</italic> and RAC1 relative to &#x003B2;-actin. (A) Immunoblot of the expression of NOX2, p47<italic>phox</italic> and RAC1 in the frontal cortex and hippocampus. (B) Corresponding densitometry for the expression levels of NOX2, p47<italic>phox</italic> and RAC1 relative to &#x003B2;-actin. Data are expressed as the mean &#x000B1; standard deviation, n=4, <sup>&#x0002A;</sup>P&lt;0.05, vs.3-month group. RAC1, Ras-related C3 botulinum toxin substrate 1; NOX2, nicotinamide adenine dinucleotide phosphate-oxidase 2.</p></caption>
<graphic xlink:href="MMR-12-03-4546-g05.jpg"/></fig></floats-group></article>
